Characterisation of a modified approach to the study of sympathetic neurotransmission and its presynaptic modulation in the isolated rabbit thoracic aorta

Journal of Pharmacological and Toxicological Methods

Volumn 46, Issue 3, 2001, Pages 145-151

  Nap, A ^a   Pfaffendorf, M ^a   Van Zwieten, P A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Conotoxin GVIA; Angiotensin II; Electrical field stimulation; Methods; Rabbit; Superfusion; Sympathetic neurotransmission; Tetrodotoxin; Thoracic aorta; Tritium

Indexed keywords

ANGIOTENSIN; GUANETHIDINE; NORADRENALIN; OMEGA CONOTOXIN GVIA; TETRODOTOXIN;

ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; FEMALE; MALE; NERVE STIMULATION; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; RABBIT; RELIABILITY; SYMPATHETIC NERVE; THORACIC AORTA;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; ELECTRIC STIMULATION; FEMALE; MALE; NOREPINEPHRINE; OMEGA-CONOTOXIN GVIA; RABBITS; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION; TETRODOTOXIN;

ORYCTOLAGUS CUNICULUS;

EID: 0035502303     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8719(02)00170-3     Document Type: Article

References (25)

1. 3H-efflux and atrial rate in guinea-pig atrium. British Journal of Pharmacology. 81:1984;201-214.
2. Balt J.C., Mathy M.J., Pfaffendorf M., van Zwieten P.A. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril. Journal of Hypertension. 19:2001;465-473.
3. Chiu A.T., Roscoe W.A., McCall D.E., Timmermans P.B. Angiotensin II-1 receptors mediate both vasoconstrictor and hypertrophic responses in rat aortic smooth muscle cells. Receptor. 1:1991;133-140.
4. Cox S.L., Ben A., Story D.F., Ziogas J. Evidence for the involvement of different receptor subtypes in the pre- and postjunctional actions of angiotensin II at rat sympathetic neuroeffector sites. British Journal of Pharmacology. 114:1995;1057-1063.
5. Cox S.L., Story D.F., Ziogas J. Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat. British Journal of Pharmacology. 119:1996;976-984.
6. Dzau V.J. Implications of local angiotensin production in cardiovascular physiology and pharmacology. American Journal of Cardiology. 59:1987;59A-65A.
7. Endo T., Starke K., Bangerter A., Taube H.D. Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Archives of Pharmacology. 296:1977;229-247.
8. Fabiani M.E., Story D.F. Inhibition of sympathetic noradrenergic transmission by guanabenz and guanethidine in rat isolated mesenteric artery: involvement of neuronal potassium channels. Pharmacological Research. 33:1996;171-180.
9. Floras J.S. Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. Journal of the American College of Cardiology. 22:1993;72A-84A.
10. Gaddum J.H. The technique of superfusion. British Journal of Pharmacology. 8:1953;321-327.
11. Göthert M., Molderings G.J. Mibefradil- and omega-conotoxin GVIA-induced inhibition of noradrenaline release from the sympathetic nerves of the human heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 356:1997;860-863.
12. Guimarães S., Paiva M.Q., Moura D. Different receptors for angiotensin II at pre- and postjunctional level of the canine mesenteric and pulmonary arteries. British Journal of Pharmacology. 124:1998;1207-1212.
13. Joseph J., Gilbert E.M. The sympathetic nervous system in chronic heart failure. Progress in Cardiovascular Diseases. 41:1998;9-16.
14. Mancia G. Sympathetic activation in congestive heart failure. European Heart Journal. 11(Suppl. A):1990;3-11.
15. Mark A.L. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. Journal of Hypertension. 14:1996;S159-S165. Suppl.
16. Mulvany M.J., Halpern W. Mechanical properties of vascular smooth muscle cells in situ. Nature. 260:1976;617-619.
17. Paterson G. The response to transmural stimulation of isolated arterial strips and its modification by drugs. Journal of Pharmacy and Pharmacology. 17:1965;341-349.
18. Reid I.A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. American Journal of Physiology. 262:1992;E763-E778. editorial.
19. Rump L.C., Schwertfeger E., Schaible U., Fraedrich G., Schollmeyer P. Beta 2-adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria. Circulation Research. 74:1994;434-440.
20. Saxena P.R. Interaction between the renin-angiotensin-aldosterone and sympathetic nervous systems. Journal of Cardiovascular Pharmacology. 19(Suppl. 6):1992;S80-S88.
21. Shetty S.S., DelGrande D. Differential inhibition of the prejunctional actions of angiotensin II in rat atria by valsartan, irbesartan, eprosartan, and losartan. Journal of Pharmacological and Experimental Therapeutics. 294:2000;179-186.
22. Storgaard T., Nedergaard O.A. Prejunctional modulation by angiotensins of noradrenaline release from sympathetic neurons in isolated rabbit aorta. Naunyn-Schmiedeberg's Archives of Pharmacology. 356:1997;706-711.
23. Su C., Bevan J.A. The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation. Journal of Pharmacological and Experimental Therapeutics. 172:1970;62-68.
24. van Zwieten P.A., de Jonge A. Interaction between the adrenergic and renin-angiotensin-aldosterone-systems. Postgraduate Medical Journal. 62(Suppl. 1):1986;23-27.
25. Wong P.C., Hart S.D., Zaspel A.M., Chiu A.T., Ardecky R.J., Smith R.D., Timmermans P.B. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). Journal of Pharmacological and Experimental Therapeutics. 255:1990;584-592.